Before joining Ratio Therapeutics, Dr. Hesterman was chief technology officer at radiology and imaging company Invirco. He eventually became CTO at Invirco’s parent company, Realm IDx, according to a Sept. 15 news release from Ratio Therapeutics.
“I believe the team at Ratio is applying cutting-edge science and technology to the development of their radiotherapeutics and I am delighted to join Ratio’s world-class co-founders, John Hoppin, PhD, and Jack Babich, PhD, in their commitment to developing effective treatments for cancer patients,” Dr. Hesterman said in the release.
